21 related articles for article (PubMed ID: 38763723)
1. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy.
Li B; Tan T; Chu W; Zhang Y; Ye Y; Wang S; Qin Y; Tang J; Cao X
Drug Deliv; 2022 Dec; 29(1):75-88. PubMed ID: 34964421
[TBL] [Abstract][Full Text] [Related]
2. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.
Abduh MS
Int J Nanomedicine; 2023; 18():5713-5732. PubMed ID: 37849642
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.
Yang X; Liang B; Zhang L; Zhang M; Ma M; Qing L; Yang H; Huang G; Zhao J
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847277
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and evaluation of HPβCD-PTX/PHB nanoparticles for pH-responsive, cytotoxic and apoptotic properties.
Aslam A; Masood F; Perveen K; Berger MR; Pervaiz A; Zepp M; Klika KD; Yasin T; Hameed A
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132268. PubMed ID: 38734336
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer.
Qian X; Yang H; Ye Z; Gao B; Qian Z; Ding Y; Mao Z; Du Y; Wang W
ACS Nano; 2024 Jun; 18(24):15864-15877. PubMed ID: 38829727
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of Asparagus racemosus willd. and Withania somnifera (L.) Dunal as chemotherapeutic adjuvants for breast cancer treatment.
Prasad K; Saggam A; Guruprasad KP; Tillu G; Patwardhan B; Satyamoorthy K
J Ethnopharmacol; 2024 Sep; 331():118261. PubMed ID: 38685363
[TBL] [Abstract][Full Text] [Related]
8. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects.
Liu R; Hou W; Li J; Gou X; Gao M; Wang H; Zhang Y; Deng H; Yang X; Zhang W
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132074. PubMed ID: 38705320
[TBL] [Abstract][Full Text] [Related]
9. mRNA-responsive two-in-one nanodrug for enhanced anti-tumor chemo-gene therapy.
Liu Y; Lin Y; Xiao H; Fu Z; Zhu X; Chen X; Li C; Ding C; Lu C
J Control Release; 2024 May; 369():765-774. PubMed ID: 38593976
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells.
Lewinska A; Adamczyk-Grochala J; Kwasniewicz E; Deregowska A; Wnuk M
Apoptosis; 2017 Jun; 22(6):800-815. PubMed ID: 28213701
[TBL] [Abstract][Full Text] [Related]
11. Construction of ROS-Responsive Hyaluronic Acid Modified Paclitaxel and Diosgenin Liposomes and Study on Synergistic Enhancement of Anti-Ovarian Cancer Efficacy.
Tang L; Wang YJ; Wang YY; Li ST; Kong L; Li XT; Ma LL; Liu XX
Int J Nanomedicine; 2024; 19():5193-5211. PubMed ID: 38859958
[TBL] [Abstract][Full Text] [Related]
12. Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy.
Mahmudi H; Shahpouri M; Adili-Aghdam MA; Akbari M; Salemi A; Alimohammadvand S; Barzegari A; Mazloomi M; Jaymand M; Jahanban-Esfahlan R
Int J Biol Macromol; 2024 Jun; 272(Pt 2):132940. PubMed ID: 38848845
[TBL] [Abstract][Full Text] [Related]
13. Biosurfactant-amphiphilized hyaluronic acid: A dual self-assembly anticancer nanoconjugate and drug vector for synergistic chemotherapy.
Badawey SE; Heikal L; Teleb M; Abu-Serie M; Bakr BA; Khattab SN; El-Khordagui L
Int J Biol Macromol; 2024 Jun; 271(Pt 2):132545. PubMed ID: 38815938
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive drug-loaded peptides enhance drug accumulation and promote apoptosis in tumor cells.
Gong Z; Zhao H; Bai J
Colloids Surf B Biointerfaces; 2024 Jul; 239():113954. PubMed ID: 38744076
[TBL] [Abstract][Full Text] [Related]
15. [Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice].
Long R; Mao X; Gao T; Xie Q; Tan H; Li Z; Han H; Yuan L
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):487-494. PubMed ID: 38864135
[TBL] [Abstract][Full Text] [Related]
16. Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy.
Cao Y; Tang L; Fu C; Yin Y; Liu H; Feng J; Gao J; Shu W; Li Z; Zhu Y; Wang W
Nano Lett; 2024 Jun; 24(22):6767-6777. PubMed ID: 38771956
[TBL] [Abstract][Full Text] [Related]
17. Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner.
Zou H; Yang Y; Chen HW
Front Pharmacol; 2023; 14():1146741. PubMed ID: 37180705
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
Sharma R; Yadav V; Jha S; Dighe S; Jain S
Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
